| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514683000 | Alicyclic ring | 6 |
| 20080306165 | Compounds for the Treatment of Metabolic Disorders - Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, poly-cystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. wherein n is 1 or 2; m is 0, 1, 2, 3, or 4; q is 0 or 1; t is 0 or 1; R | 12-11-2008 |
| 20100240766 | Agent for Improving Carcass Performance in Finishing Hogs - A food supplement for finishing hogs containing astaxanthin is described. | 09-23-2010 |
| 20120065272 | NOVEL USE OF PANDURATIN DERIVATIVES OR EXTRACT OF KAEMPFERIA PANDURATA COMPRISING THE SAME - The present invention relates to a new use of panduratin derivatives or a | 03-15-2012 |
| 20120088840 | NOVEL USE OF PANDURATIN DERIVATIVE OR BOESENBERGIA PANDURATA EXTRACT - The present invention relates to a novel use of a panduratin derivative or a | 04-12-2012 |
| 20130289128 | ARYLPROPIONYL-TRIKETONE ANTIBACTERIAL AGENTS - The invention provides a compound of formula (I): or a salt thereof, wherein R | 10-31-2013 |
| 514684000 | Five-membered alicyclic ring | 1 |
| 20110060054 | 2-METHYLENE-5-SUBSTITUTED-METHYLENECYCLOPENTANONE DERIVATIVES AND USE THEREOF - The invention relates to 2-methylene-5-substituted-methylenecyclopentanone derivatives of formula I, and the use thereof. The derivatives of formula I as active components are useful for preparing a medicine for the treatment and/or prevention of cancer diseases such as breast cancer, lung cancer, colon cancer, rectal cancer, stomach cancer, prostate cancer, bladder cancer, uterus cancer, pancreatic cancer and ovary cancer. The active compounds of the invention may be used as an anticancer drug alone or used in combination with one or more other antitumor drugs. A combined therapy can be carried out by administrating each therapeutic component concurrently, subsequently or separately. | 03-10-2011 |
